Gene · 8764
Papers3,537
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,081 to 1,100 of 3,537
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| lncRNAs Functioned as ceRNA to Sponge miR-15a-5p Affects the Prognosis of Pancreatic Adenocarcinoma and Correlates With Tumor Immune Infiltration. | Front Genet | 2022 | 35899199 | PubTator, text mining | PubMed |
| The Role of Pyrazolopyridine Derivatives on Different Steps of Herpes Simplex Virus Type-1 In Vitro Replicative Cycle. | Int J Mol Sci | 2022 | 35897709 | PubTator, text mining | PubMed |
| Emerging Promise of Computational Techniques in Anti-Cancer Research: At a Glance. | Bioengineering (Basel) | 2022 | 35892749 | PubTator, text mining | PubMed |
| The Epidemiology and Variation in Pseudorabies Virus: A Continuing Challenge to Pigs and Humans. | Viruses | 2022 | 35891443 | PubTator, text mining | PubMed |
| The Role of Latency-Associated Transcripts in the Latent Infection of Pseudorabies Virus. | Viruses | 2022 | 35891360 | PubTator, text mining | PubMed |
| Broadly Applicable, Virus-Free Dual Reporter Assay to Identify Compounds Interfering with Membrane Fusion: Performance for HSV-1 and SARS-CoV-2. | Viruses | 2022 | 35891336 | PubTator, text mining | PubMed |
| SUMOylation and Viral Infections of the Brain. | Pathogens | 2022 | 35890062 | PubTator, text mining | PubMed |
| Discovery of Long Non-Coding RNA MALAT1 Amplification in Precancerous Colorectal Lesions. | Int J Mol Sci | 2022 | 35887000 | PubTator, text mining | PubMed |
| A novel immune checkpoints-based signature to predict prognosis and response to immunotherapy in lung adenocarcinoma. | J Transl Med | 2022 | 35879761 | PubTator, text mining | PubMed |
| Single-cell transcriptome atlas of the human corpus cavernosum. | Nat Commun | 2022 | 35879305 | PubTator, text mining | PubMed |
| Concurrent Waldenstrom's Macroglobulinemia and Myelodysplastic Syndrome with a Sequent t(10;13)(p13;q22) Translocation. | Curr Oncol | 2022 | 35877223 | PubTator, text mining | PubMed |
| Controversial Role of the Immune Checkpoint OX40L Expression on Platelets in Breast Cancer Progression. | Front Oncol | 2022 | 35875148 | PubTator, text mining | PubMed |
| Comprehensive Analysis of TRP Channel-Related Genes in Patients With Triple-Negative Breast Cancer for Guiding Prognostic Prediction. | Front Oncol | 2022 | 35875096 | PubTator, text mining | PubMed |
| Soluble Immune Checkpoint-Related Proteins in Blood Are Associated With Invasion and Progression in Non-Small Cell Lung Cancer. | Front Immunol | 2022 | 35874720 | PubTator, text mining | PubMed |
| From Anti-HER-2 to Anti-HER-2-CAR-T Cells: An Evolutionary Immunotherapy Approach for Gastric Cancer. | J Inflamm Res | 2022 | 35873388 | PubTator, text mining | PubMed |
| Antibody-Targeted TNFRSF Activation for Cancer Immunotherapy: The Role of FcγRIIB Cross-Linking. | Front Pharmacol | 2022 | 35865955 | PubTator, text mining | PubMed |
| Human Hepatic CD56bright NK Cells Display a Tissue-Resident Transcriptional Profile and Enhanced Ability to Kill Allogenic CD8+ T Cells. | Front Immunol | 2022 | 35865550 | PubTator, text mining | PubMed |
| Characterization of the Immunologic Phenotype of Dendritic Cells Infected With Herpes Simplex Virus 1. | Front Immunol | 2022 | 35865514 | PubTator, text mining | PubMed |
| Circulating Tumor DNA Characteristics Based on Next Generation Sequencing and Its Correlation With Clinical Parameters in Patients With Lymphoma. | Front Oncol | 2022 | 35865478 | PubTator, text mining | PubMed |
| Identification of BST2 Contributing to the Development of Glioblastoma Based on Bioinformatics Analysis. | Front Genet | 2022 | 35865015 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8764/papers?page=55